Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

31 Jul 2020 --- Nestlé’s infant nutrition subsidiary Gerber is expanding its organic snacks range with the introduction of Gerber Organic BabyPops. The product is a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Jul 2020 --- Collagen and lactose-free A2/A2 dairy are new features of Re:THINK Ice Cream’s products, as the US-based company rethinks both its formulation and branding in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

19 Jun 2020 --- This week in nutrition news, Lallemand Health Solutions relaunched its psychobiotic formulation under the name Cerebiome. Finnish organic extracts producer Eevia... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

11 May 2020 --- Gluten-free consumer demand, research and industry innovation are being highlighted during Coeliac UK’s Gluten Free Community Week hosted May 11-17. Although... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

21 Apr 2020 --- Prepared food is the leading category for growth in infant nutrition NPD as adult themes such as free-from and superfood positionings become increasingly important... Read More

trans